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Human
Metapneumovirus
and Community-
Acquired
Respiratory Illness
in Children
To the Editor: Stockton et al. have
reported the detection of human
metapneumovirus (HMPV) by using
reverse transcriptase-polymerase
chain reaction (PCR) in patients with
influenzalike illness (1). These
authors examined specimens submit-
ted from patients, mainly adults, dur-
ing winter 2000–01 and identified
HMPV in 2.2% of patients with
influenzalike illness who had tested
negative for influenza virus and
human respiratory syncytial virus
(HRSV). Although several papers
have been published on HMPV infec-
tion in children (2–4), the real impact
of this virus on the health of the pedi-
atric population remains to be deter-
mined. The data we obtained in the
present study support the epidemio-
logic findings of J. Stockton et al. (1)
and reinforce the notion that HMPV is
a human pathogen associated with
community-acquired acute respiratory
tract infection (ARTI).
We investigated the occurrence of
HMPV in children <3 years of age
with ARTI during two consecutive
winter seasons (November 2000–
February 2001 and November 2001–
February 2002) as part of a study to
detect respiratory viruses (HRSV,
influenza A and B viruses, parain-
fluenza virus types 1–4, and aden-
ovirus) among the pediatric popula-
tion. The study population comprised
565 children who were brought to
Hospital Donostia, San Sebastián,
Spain, with reported symptoms of
ARTI, most of which (>80%) affected
the lower respiratory tract. Of these
children, 379 were hospitalized and
186 were discharged without admis-
sion. Hospital Donostia belongs to the
public health system and is the main
referral hospital for a population of
9,500 children <3 years of age. More
than 97% of hospitalizations of chil-
dren in our region occur in this hospital.
Nasopharyngeal aspirates were
obtained and processed for cell cul-
ture by using rapid shell vial tech-
niques on the MDCK, A-549, and
LLC-MK2 cell lines. RNA was then
extracted from the original samples
by using phenol-chloroform (TRIzol
LS Reagent, Invitrogen Corp.,
Carlsbad, U.K.) and was converted
into cDNA with random primers by
using M-MuLV reverse transcriptase
(USB Corp., Cleveland, OH). Nested
PCR was performed to detect HRSV,
influenza, and parainfluenza viruses
as previously described (5,6). The
remaining cDNAwas frozen at –80°C
until subsequent use. We tested for
HMPV in all samples that tested neg-
ative for the previously studied virus-
es, as well as in 100 randomly select-
ed study samples that were positive
for one or more of these viruses.
HMPV detection was performed by
PCR by using 5 µL of stored cDNA
with primers derived from the F gene
under previously described conditions
(7). The PCR product (450 bp) from
the HMPV-positive samples was
sequenced in an ABI PRISM 3100
Genetic Analyzer (Applied Bio-
systems, Foster City, CA).
In 411 (72.7%) of the 565 patients
studied, at least one of the initially
investigated viruses was detected.
HRSV was found in 313 (55.4%) chil-
dren, influenza in 44 (7.8%), parain-
fluenza in 36 (6.4%), and adenovirus
in 32 (5.7%); 14 mixed infections
were detected. Of 154 children with a
negative result, HMPV detection was
performed in 147 (95.5%), with a pos-
itive result in six children (4.1%). No
HMPV was detected in any of the 100
samples previously positive for the
initially studied respiratory viruses.
Four of the six HMPV-positive chil-
dren required hospitalization: a 7-
month-old boy with pulmonary bron-
chodysplasia, rhinitis, and fever of
38.4°C (patient 1); a 20-month-old
girl with previous obstructive pul-
monary disease who had acute respi-
ratory insufficiency along with gener-
alized hypoventilation, crackles,
wheezing, and radiologic images of
air entrapment requiring bronchodila-
tor administration (patient 2); a 16-
month-old girl who had a febrile syn-
drome, basal crackles on pulmonary
auscultation, and perihilar infiltrates
(patient 3); and an 11-month-old boy
with pneumonia of the upper left lobe
(patient 4). The two remaining
patients, a 7-month-old boy (patient
5) and a 9-month-old girl (patient 6),
both with upper respiratory symptoms
and clear chest, did not require hospi-
talization. In all six patients, outcome
was favorable.
Analysis of the amplified
sequences showed two clusters of
HMPV. The first was composed of
HMPV from patients 1, 3, 4, and 6
(GenBank accession nos. AY152846,
AY152851, AY152850, and
AY152847, respectively), and the
second was composed of HMPV
from patients 2 and 5 (GenBank
accession nos. AY152849 and
AY152848). The similarity among
nucleotide sequences in the same
cluster was >95% and oscillated from
86% to 88% when compared to those
from a different cluster. During the
second study season, we observed
circulation of both clusters. When we
compared these sequences of HMPV
F gene obtained in Spain with those
recently described in North America
(7), we found that the sequences of
the first cluster showed >95% simi-
larity with the isolate CAN97-83
(GenBank accession no. AY145296),
and the sequences from the second
cluster showed >95% similarity with
isolates CAN98-73 to CAN98-79
(GenBank accession nos. AY145287–
AY145293), connecting the Canadian
isolates to two well characterized
groups of HMPV. Our results suggest
that in Spain, as well as in otherEmerging Infectious Diseases • Vol. 9, No. 5, May 2003 603
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places in the world (2,7), two major
HMPV groups exist. The severity of
the episodes observed varied from
mild upper respiratory symptoms to
severe infections requiring hospital-
ization for 2–6 days. Overall, as
reported by other authors (2,8), the
clinical picture provoked by HMPV
was indistinguishable from that of
other respiratory viruses. The fact that
HMPV was not detected in any of the
samples from patients also positive
for other respiratory viruses suggests
that coinfection is infrequent. The
data reported in our study, obtained
during two consecutive winter sea-
sons in a pediatric population of
southern Europe, allow us to estimate
that the incidence of moderate or
severe respiratory infections caused
by HMPV is low and that the impact
of the other respiratory viruses is con-
siderably greater. Despite these
results, we think that this new respira-
tory pathogen warrants surveillance.
HMPV appears to be capable of pro-
voking severe infections, and its role
in human respiratory infections is still
poorly understood. 
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Puumala Virus
Infection with
Acute
Disseminated
Encephalomyelitis
and Multiorgan
Failure
To the Editor: Hantaviruses,
which belong to the genus
Hantavirus, family Bunyaviridae, are
human pathogens that are prevalent
worldwide (1). More than 16 different
genotypes or serotypes have been
identified (e.g., Puumala, Hantaan,
Dobrava-Belgrade, Seoul, Sin
Nombre). In western and central
Europe, the predominant serotype is
Puumala, which causes nephropathia
epidemica. Puumala virus (PUUV) is
spread by rodents and is transmitted to
humans by inhalation or ingestion of
food contaminated with rodent excre-
ta (2). Nephropathia epidemica is
endemic in western Russia, Finland,
Sweden, France, Belgium, Germany,
and former Yugoslavia. Reports of
serologically verified nephropathia
epidemica cases have also been pub-
lished from Denmark, Norway, the
Netherlands, and Austria (3). In
Austria, the risk for infection seems to
be restricted to special areas in Styria
and Carinthia where Clethrionomys
glareolus, the reservoir of PUUV in
Austria, is endemic. The seropreva-
lence in Finland is 5% and 1.8% in
Austria (4). The most common symp-
toms of nephropathia epidemica are
fever, nausea, vomiting, headache,
stomachache, back pain, tenderness in
the kidney area, diarrhea or constipa-
tion, and red throat (5). PUUV infec-
tion may also lead to neurologic
symptoms including meningoen-
cephalitis, polyradiculitis, seizures,
cerebral hemorrhage, urinary bladder
paralysis, and hypopituitarism (6,7).
Our patient, a 43-year-old previ-
ously healthy man, had a temperature
of 39°C and acute abdominal pain.
Two days after the symptoms began,
he was admitted to a regional hospital
where acute renal failure and dissem-
inated intravascular coagulation
developed in the next 2 days. The
patient was transferred to the
Department of Medicine, Karl-
Franzens University Graz, for inten-
sive care. The patient worked in a fac-
tory, and he hunted in his spare time.
A few days before his illness began,
he had cleaned up his hut in the forest. 
On admission to the intensive care
unit, physical examination showed
abdominal guarding and a body tem-
perature of 39.2°C. Laboratory tests
showed thrombocytes 36 G/L
(140–440 G/L), creatinine 3.6 mg/dL
(0.6–1.3 mg/dL), urea 132 mg/dL
(10–45 mg/dL), D-dimere 1,558 µg/L
(<200 µg/L), ATIII 67% (>75%), c-
reactive protein (CRP) 237 mg/L (<9
mg/L), lactate dehydrogenase (LDH)
322 U/L, and slightly elevated liver
enzymes. Computer tomography (CT)
of the thorax showed bilateral opaci-